Alberto Bustamante

Clínica Alemana

Papers

1

Total Citations

7

H-Index

1

About

Alberto Bustamante is a leading urologic oncologist whose research centers on the surgical management of renal cell carcinoma, with a particular focus on robot-assisted partial nephrectomy. His most cited work, a 2022 study examining long-term oncological and functional outcomes after robot-assisted partial nephrectomy for clinically localized renal cell carcinoma, has garnered 7 citations and provides critical evidence supporting the efficacy of minimally invasive nephron-sparing surgery. Bustamante’s contributions have helped refine surgical techniques that balance cancer control with renal function preservation, directly impacting clinical decision-making for patients with small renal masses. His research addresses the enduring challenge of optimizing both survival and quality of life, demonstrating that robot-assisted approaches can achieve excellent oncological results while minimizing renal impairment. Through his meticulous analysis of functional outcomes, Bustamante has advanced the understanding of how surgical precision influences long-term kidney health. His work is particularly valuable for surgeons and researchers seeking to improve patient outcomes in the era of robotic urology, establishing him as a key voice in the ongoing evolution of nephron-sparing surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Long-Term Oncological and Functional Outcomes After Robot-Assisted Partial Nephrectomy for Clinically Localized Renal Cell Carcinoma
7 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Clínica Alemana

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago